Mary L Keohan Selected Research

Aspartate Aminotransferases (Aspartate Transaminase)

1/2022	Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors.
11/2015	A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary L Keohan Research Topics

Disease

11	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 12/2003
9	Neoplasms (Cancer) 10/2023 - 05/2005
4	Hemangiosarcoma (Angiosarcoma) 01/2022 - 07/2009
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 10/2019
3	Synovial Sarcoma (Synovioma) 10/2020 - 07/2009
3	Neurofibrosarcoma (MPNST) 01/2019 - 07/2009
3	Leiomyosarcoma 01/2019 - 07/2009
2	Hypophosphatemia 01/2022 - 01/2022
2	Exanthema (Rash) 01/2022 - 01/2022
2	Fibroma (Fibromatosis) 01/2022 - 05/2010
2	Anemia 01/2022 - 01/2022
2	Aggressive Fibromatosis (Desmoid) 01/2022 - 05/2010
2	Liposarcoma 09/2009 - 07/2009
1	Arthralgia (Joint Pain) 10/2023
1	Pneumonia (Pneumonitis) 10/2023
1	Hypersensitivity (Allergy) 10/2023
1	Hypothyroidism 10/2023
1	Edema (Dropsy) 01/2022
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Fever (Fevers) 01/2019
1	Histiocytic Sarcoma 11/2015
1	Hypertension (High Blood Pressure) 11/2015
1	Hoarseness 11/2015
1	Fatigue 11/2015
1	Fibrosarcoma 07/2009
1	Malignant Fibrous Histiocytoma 07/2009
1	Solitary Fibrous Tumors 07/2009
1	Osteosarcoma (Osteogenic Sarcoma) 07/2009
1	Rhabdomyosarcoma 07/2009
1	Giant Cell Tumor of Bone 07/2009
1	Malignant Mesothelioma 05/2005
1	Hemorrhagic Cystitis 12/2003

Drug/Important Bio-Agent (IBA)

4	Immune Checkpoint InhibitorsIBA 10/2023 - 04/2014
4	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 07/2009
3	binimetinibIBA 01/2022 - 10/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 11/2015
2	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 07/2009
2	Docetaxel (Taxotere)FDA Link 11/2015 - 01/2015
2	Gemcitabine FDA Link 11/2015 - 01/2015
2	AnthracyclinesIBA 05/2010 - 09/2009
2	Ifosfamide FDA LinkGeneric 09/2009 - 12/2003
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Transaminases (Aminotransferases)IBA 10/2023
1	Programmed Cell Death 1 ReceptorIBA 03/2022
1	CreatinineIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	HLA-A Antigens (HLA-A)IBA 10/2020
1	pexidartinibIBA 10/2019
1	Tyrosine Kinase InhibitorsIBA 10/2019
1	Dacarbazine (DIC)FDA LinkGeneric 01/2019
1	Angiogenesis InhibitorsIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 11/2015
1	pazopanib FDA Link 11/2015
1	Bevacizumab (Avastin)FDA Link 01/2015
1	poly ICLCIBA 04/2014
1	AntigensIBA 04/2014
1	Monoclonal AntibodiesIBA 04/2014
1	Toll-Like Receptor AgonistsIBA 04/2014
1	resiquimodIBA 04/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2014
1	Estrogen Receptor Modulators (Antiestrogen)IBA 05/2010
1	TrabectedinIBA 09/2009
1	Phosphotransferases (Kinase)IBA 07/2009
1	Sunitinib (Sutent)FDA Link 07/2009
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2009
1	N 30IBA 07/2009
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2006
1	Mesna (Coenzyme M)FDA LinkGeneric 12/2003

Therapy/Procedure

11	Therapeutics 10/2023 - 05/2005
5	Drug Therapy (Chemotherapy) 01/2019 - 01/2006
1	Cryosurgery 01/2022
1	Drug Tapering 01/2019
1	Neoadjuvant Therapy 11/2015